Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Glucocorticoid-induced enhancement of extinction-from animal models to clinical trials
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4524136
Author(s) de Quervain, Dominique; Wolf, Oliver T.; Roozendaal, Benno
Author(s) at UniBasel de Quervain, Dominique
Year 2019
Title Glucocorticoid-induced enhancement of extinction-from animal models to clinical trials
Journal Psychopharmacology
Volume 236
Number 1
Pages / Article-Number 183-199
Keywords Clinical trials; Fear-related disorders; Glucocorticoids; Memory
Mesh terms Animals; Clinical Trials as Topic, methods; Disease Models, Animal; Emotions, drug effects, physiology; Extinction, Psychological, drug effects, physiology; Fear, drug effects, physiology, psychology; Glucocorticoids, pharmacology, therapeutic use; Humans; Memory, drug effects, physiology; Stress Disorders, Post-Traumatic, drug therapy, psychology
Abstract Extensive evidence from both animal model and human research indicates that glucocorticoid hormones are crucially involved in modulating memory performance. Glucocorticoids, which are released during stressful or emotionally arousing experiences, enhance the consolidation of new memories, including extinction memory, but reduce the retrieval of previously stored memories. These memory-modulating properties of glucocorticoids have recently received considerable interest for translational purposes because strong aversive memories lie at the core of several fear-related disorders, including post-traumatic stress disorder and phobias. Moreover, exposure-based psychological treatment of these disorders relies on successful fear extinction. In this review, we argue that glucocorticoid-based interventions facilitate fear extinction by reducing the retrieval of aversive memories and enhancing the consolidation of extinction memories. Several clinical trials have already indicated that glucocorticoids might be indeed helpful in the treatment of fear-related disorders.
Publisher SPRINGER
ISSN/ISBN 1432-2072
edoc-URL https://edoc.unibas.ch/73922/
Full Text on edoc No
Digital Object Identifier DOI 10.1007/s00213-018-5116-0
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/30610352
ISI-Number WOS:000458681900014
Document type (ISI) Journal Article, Review
 
   

MCSS v5.8 PRO. 0.351 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
26/04/2024